Pharmacovigilance is evolving with stricter EMA requirements, rising adverse event reports, and AI integration. Local Qualified Persons for PV (LQPPVs) remain critical, but outsourcing their role can ease burdens and strengthen compliance. Strategic partners bring regulatory expertise, scalable resources, and advanced technology to manage complex vendor networks while ensuring inspection readiness. AI supports faster, more accurate adverse event processing, though human expertise is vital for context and judgment. By combining local knowledge with AI and robust oversight, outsourcing future-proofs PV systems, harmonizes processes, and sustains regulatory confidence.

Join for free to read